Pharmacodynamics and Pharmacokinetics of Citalopram and Escitalopram.
Phase of Trial: Phase I
Latest Information Update: 17 Feb 2014
At a glance
- Drugs Citalopram (Primary) ; Escitalopram (Primary)
- Indications Major depressive disorder
- Focus Pharmacogenomic; Therapeutic Use
- Acronyms PGRN-AMPS
- 01 May 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 Oct 2012 Planned end date changed from 1 Feb 2020 to 1 Dec 2012 as reported by ClinicalTrials.gov.
- 18 Oct 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.